Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Out-licensing

Fluorcanasite glass ceramic for dentistry

Fusion IP
A novel, fully-synthetic fluorcanasite material

Full description

The dental market is well positioned to expand quickly over the next 30 years with 2 key underlying trends set to drive growth:

  • an ageing and relatively wealthy population in the advanced economies
  • rapid growth of a new middle-class in the emerging economies that will yield at least one billion new dental patients 

Within the dental market sector, indirect dental restorations are a large and growing market, with over 20 million dental restorations carried out in the US per year and in the UK in 1998, over 55% of dentate adults had at least one decayed or unsound tooth. 

Researchers at the University of Sheffield have developed a novel, fully-synthetic fluorcanasite material with class-leading properties and that is inexpensive to produce.  Our material, Fluorcanasite S82, is stronger than currently available materials, has higher fracture toughness, has class leading aesthetic properties and is designed to be machinable with all common CAD/CAM systems.  Fluorcanasite is strikingly more similar in appearance to a real tooth than competitor products.

Competitor material

 

Fluorcanasite S82

 

Leading aesthetic quality

Superior aesthetic quality

Requires treatment after machining

Machined in final state

Requires processing with toxic and corrosive reagents

No toxic chemical processing

Resistant to thermal shock in use

We are currently undertaking work to ensure regulatory compliance for the material and are making rapid progress towards compiling a data file suitable for applying for CE marking/FDA approval.

Development status

Early Stage

Patent information

We have filed a patent application on the material covering its use in numerous dental applications.

Type of business relationship sought

We are currently seeking a licensee for this technology, in order to bring this product to the marketplace and realise its commercial potential.

Licensing contact

Dr Andrew Tingey
IP Pipeline Manager
Request more information

More information

For more information about the product please visit website.

Company details

Fusion IP
Fusion IP turn world class university research into business by investing in the world's most exciting science

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Related items

Related categories

Partnering consultation free of charge
Bio-Europe 2008
MipTec
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us